DSS, Inc.
As of Oct 22, 2026, DSS is in Stage 1, the basing phase, now in week 12 (since Jul 30, 2026). It closed at $0.54, 61.4% below its 52-week high and below its 200-day average, which is falling.
DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is DSS early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
DSS among Packaging & Containers22nd of 23 by relative strength
All 23 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | KRT | Stage 2 · wk 31 | 96 | +1.5% |
| 2 | MYE | Stage 3 · wk 2 | 95 | +3.1% |
| 3 | GEF-B | Stage 2 · wk 15 | 94 | +4.0% |
| 4 | GEF | Stage 3 · wk 1 | 83 | −1.4% |
| 5 | BALL | Stage 3 · wk 4 | 79 | +11.9% |
| 6 | AMBP | Stage 3 · wk 3 | 79 | +6.3% |
| 7 | SON | Stage 4 · wk 1 | 75 | −0.7% |
| 8 | PKG | Stage 3 · wk 2 | 72 | +3.3% |
| …22 | DSS | Stage 1 · wk 12 | 17 | −22.7% |
DSS: quick answers
What stage is DSS in?
As of Oct 22, 2026, DSS (DSS) is in Stage 1, the basing phase. It entered Stage 1 on Jul 30, 2026 and is in week 12. What the four stages mean
Is DSS in an uptrend?
Not yet. DSS is in Stage 1, a base that can come before an uptrend. It trades 25.2% below its 200-day average, which is falling.
How far is DSS from its 52-week high?
DSS closed at $0.54 on Oct 22, 2026, 61.4% below its 52-week high of $1.39. Its 52-week low is $0.42.
How has DSS performed over the past year?
As of Oct 22, 2026, DSS is down 63.1% over the past year and down 44.5% so far in 2026.
Which sector and industry is DSS in?
DSS is in the Packaging & Containers industry, part of the Consumer Discretionary sector.
About this companyConsumer Discretionary· Packaging & Containers
DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. It invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, the company focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engages in nonbanking activities related to banking, such as loan syndication, mortgage banking, trust and escrow, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services; and operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers. Additionally, it develops and acquires assets and investments in the securities trading and funds management arena, as well as lists and operates as a digital asset on secondary market. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.